文档介绍：First, the general theory
Alzheimer's disease has e the leading killer in elderly health in China. It has e the second mon cause of life-threatening disease in the elderly after cardiovascular disease, cancer and stroke. Statistics show that the mortality rate of dementia up to % in China. Alzheimer's disease accounts for about 50% to 70% of dementia cases. Alzheimer's disease is an onset of occult progressive degenerative neurodegenerative disease that occurs in old age and pre-old age. The incidence of Alzheimer's disease in China is the same as that of the munity. This incidence multiplied by 200 million elderly population base, you can estimate the number of people with Alzheimer's disease in China between 8 million to 10 million. Currently, the number of patients with Alzheimer's disease in China has ranked first in the world, while only 21% of patients have been standardized diagnosis. It has always been the focus of people's attention to the industry. Since the opening of China's reform and opening up, the diversification of investment entities in China's pharmaceutical industry and the rapid development of medical technology have made it possible for the Chinese panies. It has laid a good foundation for the rapid development of China's pharmaceutical industry. However, at the same time, due to the influence of macroeconomic regulation and control, disorderly develo